Analytical Data
-
Gene name
CDHOB
- Application
-
Alternative Names
CDH11; CAD11; OB; OSF4; Cadherin 11 Type 2; OB-Cadherin
-
Species
Human
-
Source
E. coli
-
Tag
N- His & GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P55287
-
Expression Region
Val374~Cys595
-
Molecular Weight
55kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CDHOB, or the C-type lectin domain-containing protein involved in hepatocyte differentiation and other physiological processes, plays a crucial role in various biological functions. The study of CDHOB recombinant proteins has gained significant attention due to their potential applications in targeted therapies and biotechnological advancements. Research indicates that CDHOB is involved in cell signaling, immunological responses, and the regulation of liver function, making it a vital component in understanding diseases such as liver cirrhosis, hepatitis, and metabolic disorders. The recombinant form of this protein allows scientists to investigate its structure and functional mechanisms in detail, facilitating the development of diagnostic tools and therapeutic strategies. These proteins can be produced in heterologous systems, which simplifies the study of their biochemical properties and interactions with other biomolecules. Increasing evidence suggests that CDHOB might also play a role in modulating immune responses, highlighting its significance in both health and disease. As researchers continue to explore the intricate roles of CDHOB in biological systems, the insights gained are likely to contribute to novel interventions in liver disease management and broader applications in immunology and cell biology.
